homocysteine has been researched along with Embolism, Pulmonary in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (19.35) | 18.2507 |
2000's | 15 (48.39) | 29.6817 |
2010's | 8 (25.81) | 24.3611 |
2020's | 2 (6.45) | 2.80 |
Authors | Studies |
---|---|
Braekkan, SK; Hansen, JB; Morelli, VM; Tøndel, BG | 1 |
Gao, X; Hu, S; Hua, L; Jia, L; Jiang, X; Tan, JS; Wang, XJ; Wu, Y; Xu, XQ; Yan, XX | 1 |
Hu, Y; Li, TS; Peng, CY; Qian, YY; Wang, GY; Xie, LX; Xing, YH; Xue, H; Zhu, H | 1 |
Caussé, E; Elbaz, M; Fakhry, A; Redonnet-Vernhet, I; Sabourdy, F | 1 |
Friedman, J; Glueck, CJ; Hafeez, A; Hassan, A; Wang, P | 1 |
Karmadonova, NA; Karpenko, AA; Klevanets, JE; Kozyreva, VS; Shilova, AN; Subbotovskaya, AI | 1 |
Karpenko, AA; Klevanets, IuE; Shilova, AN | 1 |
Akhvlediani, M; Baramidze, A; Gachechiladze, D; Todua, F; Tsivtsivadze, G; Vorobiova, E | 1 |
Jakopović, M; Loncarić, V; Plestina, S; Redzepi, G; Samarzija, M; Vidjak, V; Zuljević, E | 1 |
Abbas, O; El-Gohary, GM; Eweda, II; Nammas, W; Samir, S | 1 |
Altın, R; Altuntaş, M; Atalay, F; Can, M; Tor, M | 1 |
Gala, JL; Hainaut, P; Heusterspreute, M; Jaumotte, C; Lavenne, E; Moriau, M; Verhelst, D; Wallemacq, P; Zech, F | 1 |
Law, M; Morris, JK; Wald, DS | 1 |
Blanco-Vaca, F; Cuquet, J; López, N; Mateo, J | 1 |
Al Haddabi, H; Al Kindi, S; Bayoumi, R; Dennison, D; Muralitharan, S; Pathare, A | 1 |
Blom, HJ; Bos, GM; Cattaneo, M; den Heijer, M; Eichinger, S; Gerrits, WB; Rosendaal, FR; Willems, HP | 1 |
D'Almeida, V; DA Silveira, RC; Lourenço, DM; Morelli, VM; Rodrigues, CA | 1 |
Addad, F; Ben Farhat, M; Chebbi, W; Golli, M; Hammami, M; Hammami, S; Hamzaoui, A; Kaoubaa, N; Majhoub, S | 1 |
Bezemer, ID; Doggen, CJ; Rosendaal, FR; Vos, HL | 1 |
Cushman, M | 1 |
Blom, HJ; Cannegieter, SC; Christiansen, SC; Hammerstrøm, J; Naess, IA; Romundstad, PR; Rosendaal, FR | 1 |
Aiolfi, S; Confalonieri, M; Gandola, L; Ghio, L; Mauri, F; Parigi, P; Patrini, G; Scartabellati, A | 1 |
Cattaneo, M; Falcon, CR; Mannucci, PM; Martinelli, I; Panzeri, D | 1 |
Hennekens, CH; Malinow, MR; Miletich, JP; Ridker, PM; Selhub, J; Stampfer, MJ | 1 |
Newman, JH | 1 |
Blom, HJ; Boers, GH; Kluijtmans, LA; Novakova, IR; Trijbels, FJ; Verbruggen, B | 1 |
Asti, D; Cattaneo, M; Franchi, F; Mannucci, PM; Martinelli, I; Zighetti, ML | 1 |
Hellenbrand, WE; Maheshwari, S; Wood, JC | 1 |
Bos, GM; den Heijer, M; Willems, HP | 1 |
Hui, R; Lu, Y; Zhao, Y | 1 |
Bellet, H; Bounameaux, H; Daurès, JP; Dauzat, M; de Moerloose, P; Gris, JC; Janbon, C; Laroche, JP; Mercier, E; Perneger, TV; Quéré, I; Schved, JF; Zittoun, J | 1 |
3 review(s) available for homocysteine and Embolism, Pulmonary
Article | Year |
---|---|
Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review.
Topics: Anticoagulants; Biomarkers; C-Reactive Protein; Homocysteine; Humans; Ischemic Stroke; Pulmonary Embolism; Risk Factors; Stroke; Venous Thromboembolism | 2022 |
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.
Topics: Cohort Studies; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Myocardial Ischemia; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2002 |
Epidemiology and risk factors for venous thrombosis.
Topics: Age Factors; Homocysteine; Humans; Incidence; Obesity; Pulmonary Embolism; Recurrence; Risk Factors; Venous Thrombosis | 2007 |
3 trial(s) available for homocysteine and Embolism, Pulmonary
Article | Year |
---|---|
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Proportional Hazards Models; Pulmonary Embolism; Pyridoxine; Recurrence; Risk Factors; Thrombophilia; Treatment Failure; Venous Thrombosis; Vitamin B 12 | 2007 |
Homocysteine reduction by B-vitamin supplementation increases t-PA and PAI-1 levels in patients with venous thromboembolism.
Topics: Adolescent; Adult; Aged; Dietary Supplements; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Pyridoxine; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Vitamin B 12; Vitamin B Complex | 2007 |
Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
Topics: Adult; Aged; Aged, 80 and over; Comorbidity; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Netherlands; Prospective Studies; Pulmonary Embolism; Pyridoxine; Retrospective Studies; Secondary Prevention; Thrombophilia; Thrombophlebitis; Treatment Outcome; Ultrasonography; Venous Thrombosis; Vitamin B 12 | 2000 |
25 other study(ies) available for homocysteine and Embolism, Pulmonary
Article | Year |
---|---|
Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism.
Topics: Case-Control Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Pulmonary Embolism; Recurrence | 2021 |
[Association between serum homocysteine and in-hospital death in patients with acute pulmonary embolism].
Topics: Aged; Female; Homocysteine; Hospital Mortality; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pulmonary Embolism; Risk Factors | 2013 |
[Pulmonary embolism in young adults. Think of homocysteine].
Topics: Adult; Anticoagulants; Biomarkers; Drug Therapy, Combination; Female; Heparin; Homocysteine; Humans; Hyperhomocysteinemia; Pulmonary Embolism; Risk Factors; Treatment Outcome; Vitamin B 6; Vitamin B Complex; Young Adult | 2014 |
Testosterone therapy, thrombophilia, and hospitalization for deep venous thrombosis-pulmonary embolus, an exploratory, hypothesis-generating study.
Topics: Homocysteine; Hormone Replacement Therapy; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Models, Biological; Polymerase Chain Reaction; Pulmonary Embolism; Risk Factors; Testosterone; Thrombophilia; Thrombosis; Warfarin | 2015 |
Association of folate metabolism gene polymorphisms and pulmonary embolism: A case-control study of West-Siberian population.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Alleles; Case-Control Studies; Female; Ferredoxin-NADP Reductase; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Probability; Pulmonary Embolism; Siberia | 2015 |
[Pulmonary artery thromboembolism on the background of hyperhomocysteinemia].
Topics: Aged; Angiography; Diagnosis, Differential; Endovascular Procedures; Female; Homocysteine; Humans; Hyperhomocysteinemia; Multidetector Computed Tomography; Pulmonary Embolism; Thrombectomy; Thrombolytic Therapy; Ultrasonography, Doppler | 2015 |
[PROGNOSTIC VALUE OF SOME HEMOSTASIS-RELATED, HOMOCYSTEINE, HIGH SENSITIVE C R P AND MULTIDETECTOR COMPUTED TOMOGRAPHY PARAMETERS IN PULMONARY EMBOLISM].
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Homocysteine; Humans; Male; Middle Aged; Multidetector Computed Tomography; Prognosis; Pulmonary Embolism; Young Adult | 2016 |
Pulmonary hypertension in patient with elevated homocystein level and blast injuries.
Topics: Adult; Blast Injuries; Homocysteine; Humans; Hypertension, Pulmonary; Male; Pulmonary Embolism; Streptokinase; Thrombolytic Therapy | 2009 |
Right heart thrombus-in-transit with pulmonary embolism in a patient with primary hypercoagulable state.
Topics: Biomarkers; Cardiopulmonary Bypass; DNA Mutational Analysis; Echocardiography, Transesophageal; Embolectomy; Factor V; Female; Heart Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Pulmonary Embolism; Thrombophilia; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome; Up-Regulation | 2010 |
Serum asymmetric dimethylarginine, nitrate, vitamin B(12), and homocysteine levels in individuals with pulmonary embolism.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Female; Homocysteine; Humans; Male; Middle Aged; Nitrates; Oxygen; Partial Pressure; Predictive Value of Tests; Prognosis; Pulmonary Embolism; Pulmonary Wedge Pressure; Risk Factors; Vitamin B 12 | 2011 |
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Belgium; Case-Control Studies; Fasting; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prospective Studies; Protein C Deficiency; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
Patient presenting multiple consecutive venous and arterial thrombotic events despite intensive conventional treatment: response after normalization of plasma homocysteine and N-acetylcysteine therapy.
Topics: Acetylcysteine; Fatal Outcome; Fibrinolytic Agents; Homocysteine; Humans; Male; Middle Aged; Pulmonary Embolism; Streptokinase; Thrombosis; Venous Thrombosis | 2003 |
Hereditary thrombophilia in ethnic Omani patients.
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders, Inherited; Blood Proteins; Case-Control Studies; Child; DNA Mutational Analysis; Female; Homocysteine; Humans; Male; Middle Aged; Oman; Pulmonary Embolism; Thrombophilia; Thrombosis; Venous Thrombosis | 2006 |
[Pulmonary embolism and Behçet's disease].
Topics: Adult; Anticoagulants; Behcet Syndrome; Colchicine; Cyclophosphamide; Female; Glucocorticoids; Gout Suppressants; Homocysteine; Humans; Immunosuppressive Agents; Male; Prednisone; Pulmonary Embolism | 2006 |
No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
Topics: Adolescent; Adult; Aged; Alleles; Biomarkers; DNA; Factor V; Female; Follow-Up Studies; Genotype; Homocysteine; Humans; Incidence; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Netherlands; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Prothrombin; Pulmonary Embolism; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Venous Thrombosis | 2007 |
Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Epidemiologic Methods; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pulmonary Embolism; Venous Thrombosis | 2008 |
Heterozygosity for homocysteinuria: a detectable and reversible risk factor for pulmonary thromboembolism.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Female; Heparin; Heterozygote; Homocysteine; Humans; Pulmonary Embolism; Pyridoxine; Recurrence; Risk Factors; Thrombolytic Therapy; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1995 |
High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
Topics: Administration, Oral; Adolescent; Adult; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Pedigree; Prevalence; Pulmonary Embolism; Thromboembolism | 1994 |
Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.
Topics: Aged; Alcohol Drinking; Blood Pressure; Boston; Case-Control Studies; Comorbidity; Diabetes Mellitus; Factor V; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Embolism; Risk Factors; Smoking; Thromboembolism; Thrombophlebitis | 1997 |
Recent trends in venous thrombosis and pulmonary embolism.
Topics: Antiphospholipid Syndrome; Factor V; History, 19th Century; History, 20th Century; Homocysteine; Humans; Neoplasms; Pulmonary Embolism; Research; Thromboembolism; Thrombophlebitis | 1997 |
Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis.
Topics: Adolescent; Adult; Child, Preschool; Cystathionine beta-Synthase; DNA Mutational Analysis; Factor V; Female; Homocysteine; Homocystinuria; Homozygote; Hot Temperature; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Protein Denaturation; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombophlebitis | 1998 |
Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels.
Topics: Adolescent; Adult; Fasting; Female; Homocysteine; Humans; Male; Middle Aged; Peptide Fragments; Protein C; Prothrombin; Pulmonary Embolism; Reference Values; Thrombophlebitis | 1998 |
Pulmonary thrombosis, homocysteinemia, and reperfusion edema in an adolescent.
Topics: Adolescent; Angiography; Cardiac Catheterization; Cardiomegaly; Chronic Disease; Constriction, Pathologic; Dyspnea; Echocardiography; Edema; Electrocardiography; Female; Follow-Up Studies; Heparin; Homocysteine; Humans; Obesity; Pulmonary Artery; Pulmonary Embolism; Risk Assessment | 2000 |
[Plasma total homocysteine and pulmonary thromboembolism].
Topics: Adult; Aged; Female; Homocysteine; Humans; Male; Middle Aged; Pulmonary Embolism | 2000 |
Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
Topics: Adult; Aged; Case-Control Studies; Erythrocytes; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Pulmonary Embolism; Risk Factors; Tetrahydrofolates; Venous Thrombosis | 2002 |